Search

The article presents a case study that determines the side effects of adalimumab, apremilast and brodalumab. It highlights the case of two women patients and their respective complications of psoriasis after receiving the said treatments. It also mentions the therapeutic intervention given to the patient to help improve their condition.

The article presents a case study of a 27-year-old woman who was diagnosed with intracranial hypertension syndrome while receiving ustekinumab for psoriasis.

The article presents a case study of an 82-year-old woman with asymptomatic nodules on the left shin who developed lymphoproliferative disorder while receiving treatment with methotrexate for psoriasis and mentions persisted post-inflammatory hyperpigmentation after three months follow-up.

The article presents the case study of a 39-year-old woman who had been receiving treatment with anti-tumor necrosis factor and developed psoriasis while receiving treatment with adalimumab for Crohn's disease and mentions the treatment of psoriasis with ustekinumab.

The article presents a case study of a 64-year-old woman with rapid alopecia affecting the scalp, eyelashes, eyebrows, arms, and legs who developed alopecia areata while receiving treatment with acitretin for psoriasis vulgaris.

The article presents a case study of a 66-year-old man who developed paradoxical exacerbation of latent interstitial pneumonia during his secukinumab treatment for psoriasis vulgaris.

The article presents a case study of a 64-year-old man who developed psoriasis during the administration of dupilumab for atopic dermatitis.

The article presents a case study of a patient of unstated age and sex who experienced increase in creatinine level following treatment with ciclosporin for psoriasis.

The article presents a case study of a 61-year-old man who developed multiple lentigines while receiving apremilast for treatment of psoriasis.

A case study is presented of a 32-year-old man developed lentigines following treatment with ustekinumab for plaque psoriasis.

The article presents a case study of a 24-year-old man with a medical history of psoriasis who developed several symptoms such as pneumonia, diarrhea, and herpes zoster while receiving treatment with adalimumab for psoriasis and psoriatic arthritis.

The article presents a case study of a 41-year-old woman with Crohn's disease and psoriasis and developed a fulminant colitis after receiving her first dose of secukinumab.

The article presents a case study of a woman in her 50s who experienced impaired kidney function, macrocytic anaemia, odynophagia, pancytopenia, psoriasis plaques and ulceration of oral mucosa following treatment of methotrexate for her psoriasis.

The article presents case studies of elderly patients who developed pruritus during treatment with adalimumab, secukinumab and ustekinumab for psoriasis vulgaris.

This article presents a case study of a female patient who developed neutropenia after treatment for psoriasis with secukinumab.

This article presents a case study of 28 patients who developed liver function test abnormalities during treatment for psoriasis with secukinumab.

This article presents a case study of a patient with localized inflammatory reactions at injection sites during treatment for psoriasis with methotrexate.

The article presents a case study of a 42-year old man who developed paradoxical neurologic and parotid sarcoidosis while receiving treatment with infliximab for refractory psoriasis.

The article presents a case study of a 54-year-old woman who experienced Strongyloides stercoralis infestation and reactivation of Chagas disease while receiving etanercept, methotrexate and prednisone for psoriasis and arthritic psoriasis.

The article presents a case study of a 33-year-old man who developed paradoxical reactions that present as panuveitis, optic nerve head granuloma and granulomatous interstitial lung disease during adalimumab treatment for psoriasis.

The article presents a case study of a 37-year-old woman who developed demyelination during adalimumab treatment for chronic plaque psoriasis.

The article presents a case study of a 45-year old woman who had spontaneous abortion after receiving treatment with secukinumab for cutaneous psoriasis.

The article presents a case study of a patient, who had developed drug eruption while receiving secukinumab and ixekizumab as treatment for plaque psoriasis.

The article reports on a study indicating safety in treating patients suffering psoriasis with ustekinumab despite its potential in reactivating hepatitis B virus (HBV) infections.

The article presents a case study of a 45-year-old man who developed oral lichenoid while treating with secukinumab for severe chronic plaque psoriasis.

The article presents a case study of a patient who developed folliculitis after receiving treatment with desoximetasone for scalp psoriasis in an open-label, observational study that included 20 patients.

The article presents a case study of a patient, with psoriasis, who experienced injection site reaction after treatment with secukinumab.

The article presents a case study of a 30-year-old man who developed infliximab induced paradoxical psoriasis' exacerbation after treatment with ustekinumab.

The article presents a case study of a 54-year-old man who developed erythrodermic psoriasis following discontinuation of adalimumab treatment.

The article describes the cases of 20 patients who developed liver fibrosis and elevation of procollagen-3 N-terminal peptide (PIIINP) during treatment with methotrexate for psoriasis.

The article describes the case of a 49-year-old man who developed bilateral macular toxicity during treatment with methoxsalen for metamorphopsia in both eyes.

A case study is presented of a 47 year old woman who presented with an injection site reaction after being treated with ixekizumab for psoriasis,.

The article presents a case study of a patient with impaired liver function following treatment with amoxicillin and methotrexate during treatment of psoriatic erythroderma, and was later discharged after hospitalization.

The article presents a case study of a 67-year-old man, who developed diarrhoea during treatment with apremilast and secukinumab for treatment of severe recalcitrant plaque psoriasis and psoriatic arthritis.

The article presents a case study of a 40-year-old woman, with psoriasis, who developed pulmonary sarcoidosis-like reaction and paradoxical cutaneous during treatment with adalimumab.

The article presents a case study of a 40-year-old woman who developed aseptic meningitis after receiving a treatment with adalimumab for psoriasis.